-
Mashup Score: 1Genotype-Guided P2Y12 Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients - 4 hour(s) ago
To test the feasibility and safety of genotype guidance in the selection of P2Y12 monotherapy within 1 week of percutaneous coronary interventions (PCIs) among patients with high bleeding risk (HBR).
Source: www.mayoclinicproceedings.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
BACKGROUND: In the AUGUSTUS trial (An Open-Label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs Vitamin K Antagonist and Aspirin vs Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention), the combination of dual antiplatelet therapy plus oral anticoagulation increased the risk of bleeding without reducing ischemic events compared with a P2Y12 inhibitor plus oral anticoagulation among patients with atrial fibrillation and acute coronary syndrome or elective percutaneous coronary intervention. However, AUGUSTUS enrolled patients up to 14 days after acute coronary syndrome or percutaneous coronary intervention, and there may be a benefit to dual antiplatelet therapy plus oral anticoagulation early after an ischemic event. METHODS: In this secondary analysis of AUGUSTUS, we divided patients into groups based on whether they were enrolled <6 days (early) or ≥6 days (later) after t
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 7Coronary Sinus Reducer Improves Angina, Quality of Life, and Coronary Flow Reserve in Microvascular Dysfunction: - 18 day(s) ago
AbstractBackgroundCoronary microvascular dysfunction (CMD) is a common cause of angina with no obstructive coronary artery disease (ANOCA), and effective treatment options are limited.ObjectivesThi…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
BACKGROUND: In the AUGUSTUS trial (An Open-Label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs Vitamin K Antagonist and Aspirin vs Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention), the combination of dual antiplatelet therapy plus oral anticoagulation increased the risk of bleeding without reducing ischemic events compared with a P2Y12 inhibitor plus oral anticoagulation among patients with atrial fibrillation and acute coronary syndrome or elective percutaneous coronary intervention. However, AUGUSTUS enrolled patients up to 14 days after acute coronary syndrome or percutaneous coronary intervention, and there may be a benefit to dual antiplatelet therapy plus oral anticoagulation early after an ischemic event. METHODS: In this secondary analysis of AUGUSTUS, we divided patients into groups based on whether they were enrolled <6 days (early) or ≥6 days (later) after t
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 6Current updates in radiocontrast-associated acute kidney injury - 24 day(s) ago
Contrast-associated acute kidney injury (CA-AKI) is an abrupt decline in kidney function occurring after a recent exposure to iodinated radiocontrast media. CA-AKI presents as elevated serum creati…
Source: www.tandfonline.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
Regional wall motion abnormalities in transthoracic echocardiography in patients with significant coronary artery disease and coronary collateral circulation in adults
Source: www.crtonline.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 12Intracardiac Ultrasound and Mapping Integration-Guided Endomyocardial Biopsy for the Diagnosis of Myocardial Melanoma Metastasis: - 8 month(s) ago
Graphical abstract
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2Changes in Operator’s Heart Rate and Blood Pressure During Chronic Total Occlusion Percutaneous Coronary Intervention: - 9 month(s) ago
∗Department of Interventional Cardiology and Angiology, National Institute of Cardiology Warsaw, Alpejska 42, 04-628 Warsaw, Poland. E-mail: E-mail Address: [email protected] Drs Januszewicz and Witkowski contributed equally to this work. Drs Januszewicz and Witkowski contributed equally to this work. Copyright © 2024, American College of Cardiology Foundation. Published by Elsevier Published online March 6,
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 11Tricuspid regurgitation burden following transcatheter aortic valve replacement requiring early pacemaker implantation - 9 month(s) ago
Conduction abnormality requiring the implantation of a permanent pacemaker (PPM) is a well-known and clinically important complication of transcatheter aortic valve replacement (TAVR). However, PPM implantation may result in lead-associated tricuspid …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19Clear lungs: Rare procedure BS&W doctor learned at Mayo Clinic has Salado man breathing deeply - 10 month(s) ago
Kerry Johnson has a thing for classic cars, and for years he has spent free time tinkering with his 1964 Chevelle and 1993 Corvette. But in December of last year,
Source: www.tdtnews.comCategories: General Medicine News, CardiologistsTweet
I knew somebody would do this. Nicely done @mandeep_mayo and @MayoClinicCV Genotype-Guided P2Y12 Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients - Mayo Clinic Proceedings https://t.co/f6Ysk2Ezkh